Bespak confirms completion of inhaled and nasal drug delivery business separation from Recipharm to focus on the transition to low GWP pMDIs
Spin-out unites three sites to create a leading global CDMO as further significant investments announced at Holmes Chapel siteHolmes Chapel, UK, and Stockholm, Sweden; Tuesday 2nd April 2024 (Business Wire) — Bespak today announced the completion of the transaction to separate Recipharm’s former Advanced...